1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with Carcinoma, Anaplastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, D; Isonishi, S; Iwamori, M; Kiguchi, K; Mikami, M; Takada, H; Tanaka, K | 1 |
| Inokuchi, J; Inoue, M; Kyogashima, M; Seto, A | 1 |
2 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Possible involvement of glycolipids in anticancer drug resistance of human ovarian serous carcinoma-derived cells.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma; Cell Line, Tumor; Cell Survival; Cholesterol; Cisplatin; Drug Resistance, Neoplasm; Female; Glycolipids; Glycosyltransferases; Humans; Inhibitory Concentration 50; Morpholines; Multidrug Resistance-Associated Proteins; Ovarian Neoplasms; Paclitaxel; Phospholipids; Sialyltransferases | 2012 |
Glucosylceramide synthetase inhibitor, D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol exhibits a novel decarcinogenic activity against Shope carcinoma cells.
Topics: Animals; Antineoplastic Agents; Carcinoma; Cell Division; Glucosyltransferases; Mice; Mice, Nude; Morpholines; Neoplasms, Experimental; Rabbits; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1996 |